# Director, US Medical Affairs, NSCLC at Revolution Medicines

- Company: Revolution Medicines
- What the company does: Backed by GV.
- Type: Startups
- Level: Principal and up
- Location: Remote (United States)
- Work setup: Remote
- Posted: 2026-11-02
- Apply by: 2026-12-17
- Apply: https://www.revmed.com/careers-list/?gh_jid=8111436003&utm_source=1752vc&utm_medium=careers
- Page: https://www.1752.vc/careers/jobs/revolution-medicines-director-us-medical-affairs-nsclc/

## About the role

The Director, US Medical Affairs – Non-Small Cell Lung Cancer (NSCLC) will support the development of the US medical strategy and lead execution of assigned medical priorities across the NSCLC portfolio. The role spans first-line and subsequent-line treatment settings and includes pre-launch planning, launch readiness, post-approval medical activities, and lifecycle planning. Found on 1752vc Careers, the job board for startup and VC roles.

## What they're looking for

- Advanced clinical or scientific degree such as PharmD, PhD, MD, DO, or equivalent
- 10+ years of relevant experience in biotechnology or pharmaceutical Medical Affairs and/or clinical oncology practice, including substantive hands-on Medical Affairs experience
- Strong scientific background in lung cancer, with direct NSCLC experience and an understanding of biomarker-driven treatment and the US treatment landscape
- Demonstrated ability to analyze, synthesize, and communicate complex clinical evidence with scientific accuracy and appropriate balance
- Hands-on experience across core Medical Affairs activities, including medical planning, external expert engagement, field medical partnership, medical communications, evidence generation, congresses, advisory boards, and training
- Demonstrated ability to collaborate and influence across functions, manage multiple projects and stakeholders, and deliver against agreed priorities

Tags: US Medical Affairs

Source: 1752vc Careers, https://www.1752.vc/careers/jobs/revolution-medicines-director-us-medical-affairs-nsclc/
